Edition:
United Kingdom

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

5.90EUR
21 Sep 2018
Change (% chg)

€-0.06 (-1.01%)
Prev Close
€5.96
Open
€6.06
Day's High
€6.06
Day's Low
€5.90
Volume
22,753
Avg. Vol
52,677
52-wk High
€7.63
52-wk Low
€2.91

Chart for

About

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and... (more)

Overall

Beta: -0.01
Market Cap(Mil.): €139.64
Shares Outstanding(Mil.): 38.42
Dividend: --
Yield (%): --

Financials

  B8FGn.DE Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.46 -- --
ROI: -184.45 15.07 14.61
ROE: -276.38 16.59 16.33

BRIEF-Biofrontera Comments On Tender Offer By Deutsche Balaton

* Said on Thursday Comments On Tender Offer By Deutsche Balaton

03 Aug 2018

BRIEF-Deutsche Balaton Biotech: Alternative Consideration To Offer For Biofrontera Shares

* SAID ON FRIDAY WITHIN THE OFFER FOR BIOFRONTERA SHARES, A WARRANT IS LISTED ON THE OPEN MARKET OF THE HANSEATIC STOCK EXCHANGE HAMBURG ON JULY 20, 2018 WITH 5.04 EUROS

23 Jul 2018

Earnings vs. Estimates